A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
Haverkos, Brad, Cortright, Katie, Andritsos, Leslie A., Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Goldenberg, David M., Wegener, William, Devine, Steven M., Jaglowski, SamanthaVolume:
21
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2014.11.529
Date:
February, 2015
File:
PDF, 233 KB
english, 2015